共 21 条
[1]
Bradley J, 2011, 53 ANN M AM SOC RAD
[2]
A PHASE I/II RADIATION DOSE ESCALATION STUDY WITH CONCURRENT CHEMOTHERAPY FOR PATIENTS WITH INOPERABLE STAGES I TO III NON-SMALL-CELL LUNG CANCER: PHASE I RESULTS OF RTOG 0117
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2010, 77 (02)
:367-372
[4]
Burdett S, 1998, LANCET, V352, P257
[5]
A RANDOMIZED PHASE-I/II TRIAL OF HYPERFRACTIONATED RADIATION-THERAPY WITH TOTAL DOSES OF 60.0 GY TO 79.2 GY - POSSIBLE SURVIVAL BENEFIT WITH GREATER-THAN-OR-EQUAL-TO 69.6 GY IN FAVORABLE PATIENTS WITH RADIATION-THERAPY ONCOLOGY GROUP STAGE-III NON-SMALL-CELL LUNG-CARCINOMA - REPORT OF RADIATION-THERAPY ONCOLOGY GROUP 83-11
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1990, 8 (09)
:1543-1555
[6]
Dautzenberg B, 1999, CANCER-AM CANCER SOC, V86, P265, DOI 10.1002/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO
[7]
2-B
[9]
Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
2006, 66 (01)
:108-116
[10]
Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer
[J].
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,
1995, 33 (05)
:993-1000